Filing Details
ROCKET PHARMACEUTICALS, INC. (NASDAQ:RCKT) filed a Form 8-K with the Securities and Exchange Commission on June 30, 2026, disclosing a material event.
8k filedNASDAQ:RCKT
ROCKET PHARMACEUTICALS, INC. (RCKT) Reports Material Event to SEC
Filing Details ROCKET PHARMACEUTICALS, INC. (NASDAQ:RCKT) filed a Form 8-K with the Securities and Exchange Commission on June 30, 2026, disclosing a material event. Market…
Market Context
ROCKET PHARMACEUTICALS, INC.'s stock currently trades at $3.42 with a market capitalization of $372.8M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for ROCKET PHARMACEUTICALS, INC.'s stock.
All SEC filings for ROCKET PHARMACEUTICALS, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View RCKT Stock Page
Frequently Asked Questions
Where can I read RCKT's SEC filings?
Browse all filings on our RCKT SEC filings page.
What types of SEC filings does ROCKET PHARMACEUTICALS, INC. file?
Public companies like ROCKET PHARMACEUTICALS, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.